A comprehensive report of survey results regarding the importance of over-the-counter medicines to consumers and medical professionals in the United States.
During this episode, get a behind-the-scenes look at CHPA’s policy priorities and the role that the new Congress plays in shaping healthcare from CHPA’s Federal Government Affairs Vice President Marc Schloss and Director Taylor Holgate.
For its annual year-in-review series, Chain Drug Review featured CHPA's President & CEO, Scott Melville, who offered industry insights from last year and thoughts on the outlook for 2021.
